Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00376532 · ClinicalTrials.gov registry record
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 63
- Enrollment target
NCT00376532 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 63 participants.
The verdict
NCT00376532 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
Assess whether serum levels of MMP 2 and or MMP 9 correlate with episodes of ventricular tachycardia or fibrillation in patients who have implantable cardioverter defibrillator devices.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00376532
The ClinicalTrials.gov registry entry for NCT00376532 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00376532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00376532 about?
NCT00376532 is a clinical study titled "Extracellular Matrix Marker of Arrhythmia Risk (EMMA)". Assess whether serum levels of MMP 2 and or MMP 9 correlate with episodes of ventricular tachycardia or fibrillation in patients who have implantable cardioverter defibrillator devices.
What is the current status of trial NCT00376532?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2006-09. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00376532?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.